{"name":"Myosin Therapeutics Inc.","slug":"myosin-therapeutics-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxOU3N1M2NTQzZCMkg2SzR1N0JjUWo5NVRzQnc5bUwzMFZ3dTZDb09MUmJ6NFlDOTkzdkdodFRhVnFaR05RaVZScXpwMmMyb09jZGtIQmo0VUpGX0JCXzRXeGd5anB6OW56V1BqTXE1clk4UklTX21GVWZhQ2dWODF6a0JtT1ZVSjlsSFdPQ1praUVtSnNyaDJXQ3pEZFFKUF8yM0xGbTRYMA?oc=5","date":"2026-03-31","type":"trial","source":"BioWorld News","summary":"Braveheart finds phase II positive for cardiac myosin inhibitor - BioWorld News","headline":"Braveheart finds phase II positive for cardiac myosin inhibitor","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMi6wFBVV95cUxNUlNGclp3MUt4VDVCLUJTYkgyaWo4VVhrYWVYcFVJR0ZOWXQ5aEtOdk1KMFlCZEgxWVVidzhRM1F6Y0xmRXpJakxDQ05qNmJ1TWl0bVpGeHdvU0FfLXNFNVRtbDFZdmhOMTRyN3NMY25ZOFJ2RXdPXzlTWElRa0xaT1k2V1ZCTmdqVkdjaVVNaVRjclNUVE42SWpJcmhIMF9KSXBkbVlXUlByYlpYTHNnakhPb0pGRXd0T0MzcW9LaVNDejI0NFItMWJ1dWlqa3lmd09qNldLTVB2R2ZGZDJ3RS01V05DOWdrc1hN?oc=5","date":"2026-03-24","type":"trial","source":"PR Newswire","summary":"Myosin Therapeutics Awarded Florida Cancer Innovation Fund Grant to Support STAR-GBM Clinical Trial - PR Newswire","headline":"Myosin Therapeutics Awarded Florida Cancer Innovation Fund Grant to Support STAR-GBM Clinical Trial","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAJBVV95cUxPWENFSXJzREpzNkJ0ZkZmcjBaQlA3S3lpTlhnTnFfYkNyV0YxLUtfMW55aEI4czJwMVgwLWhQSlpVOU0tYUY1Q2lHa29QbkhuMXZFTE9YaGtLQjMxVXBUZlRlaFJfTnJyY1pvVkpQa0RWanZMOWdTdmhjYUZFQzdHZndYWFp2MkZuanlMZEhTcW9qQXRGV0dJVWdYT3Q1OTNfUllXNU9jZFhCclI3WjNMNWVWejN0U2dQZDRPN2pwQ2Q1ZWNXVGlUUjZkamVWbkltWWh2VmptSEoxMENtREsxNnVIdlJ5SWhCLVdmV0M3STgzdk15WlQwYXg1d2FIQXBlRmhGemk0MFJ3QkZsVzJZVmxYSTFySTBf?oc=5","date":"2026-03-09","type":"pipeline","source":"mykxlg.com","summary":"Myosin Therapeutics Invited to Present at Two South Florida Life Sciences Conferences - mykxlg.com","headline":"Myosin Therapeutics Invited to Present at Two South Florida Life Sciences Conferences","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi6wFBVV95cUxNb3c0VDUxMEgxa3Z3ZkhtT0FrNXZoRmt0cUlKYm9IdW52OWl4ajhNOGxCSGtyNUI0OTgyM0U0ODUzNi1jaFg4SVNRQmZOb2J1X19LdDRBLTN0azdYU245Y1hTR3lkVnliQ3BOR3U3M283ZWxpeERmY0RQU00zTzdfRUIweE1KMk9xc3NiOXFoODRpRTR6aU0wNVNXTXhrVkpwM0N1bGdmTjVYc0t3d1RtNlZ5RS13WWphU3pJaE5kVlhGMTRmV3dNXzc2WThLREdkazlrRjVUY3RCdHhEWUhVRG9jVHZscGVYdjBN?oc=5","date":"2026-01-29","type":"deal","source":"PR Newswire","summary":"Myosin Therapeutics Invited to Present at Biocom California's Global Partnering & Investor Conference - PR Newswire","headline":"Myosin Therapeutics Invited to Present at Biocom California's Global Partnering & Investor Conference","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxQQWF4bjBGZURZNXMyM2dVMGl2eURNclVlcUFjbFpxXy1TLV9mb0Myc1lhTFlUVG9lSm1YaEd5bkFSN3dReGtLRkFGaHdWQ3EtQWNYTzJOTnNOSFlSTVE2UVF4LXNab0s2V1ZtVzl4WHBpN2ctY0lQVGhBQUFCb1JtM1IySjFmaDlLQ2ZCYVhfQms5RTIzVXo2RXA4R2plVF9mYlBF?oc=5","date":"2025-11-04","type":"regulatory","source":"Oncology News Central","summary":"Oncology Drugs Fast-Tracked by the FDA in October 2025 - Oncology News Central","headline":"Oncology Drugs Fast-Tracked by the FDA in October 2025","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxOX1UyTE96QzZkWW0yV3JHNzBGWFFYemJWblBCMEdoQ19kM3N5MjBaOEc4SjFBRW9nQjBPbmVNaDJzX2F3TXVaMFdHdmZNWnZDaW9QOFA1Vk5VbzV5U1pFVWFKN3ZZVGVBZVRPNGo1M1pCR05EVGgzdEozbWpLc1VlWkNCRmlJV0tpUHBxbldqeXZhT0pTOWdMUWYySVRoS041TmMwc1hyeTNRaVZRTzlZ?oc=5","date":"2025-11-03","type":"pipeline","source":"WPBF","summary":"Local team of neuroscientists reaches major milestone in brain cancer research - WPBF","headline":"Local team of neuroscientists reaches major milestone in brain cancer research","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1AFBVV95cUxNU01rc0tJdWQySFNqbVJ5WkMzb2pTc0FxdG1LalBXX3c3MlVBX09iaTB4TGptYVJPZ1pNZEYtdVBVbXZ1QUFpRzY4QWJENzVJX2wwOGx4T3d3cHd3MUFEVFZ3NnpCRzl1N0tFUzRNUEJDQnhUbVc5Q3d1ck1jem9mekt1R2JXMHhjS1ZVNXktSDVHeDg4X1hla1RhWUlFcDhIT05uUFdTVEwyU3pjME9CVW1NSVFSSzlRM1hscGdkYXRQbTFfT3lZMWx6TlZpMnR1dWl4Tw?oc=5","date":"2025-10-22","type":"regulatory","source":"PR Newswire","summary":"Myosin Therapeutics Receives FDA Fast Track Designation for MT-125 in Glioblastoma - PR Newswire","headline":"Myosin Therapeutics Receives FDA Fast Track Designation for MT-125 in Glioblastoma","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxOMWswcTh6eW94QkdjQldfTEsyS2thU3RuZDA2VlNveWtfVzRhUUJFZTN0QjlVYUhEUldTZTNZXzZvanFvc1VGbnJxSkM1akU0QnNFRzgwRlBON1RRTHlYMnM1VDBMMXFOcWdyZTRKOWF3cXJhRTU3MjlBd1Nzem9VZTFLZkRrNWp5VEtsWnowUnE5UjdaQnJUeE9uQzlsUVNRaDI5VTVzQlM2R0FpRkFB?oc=5","date":"2025-09-05","type":"pipeline","source":"BioPharma Dive","summary":"Bravehart, a stealthy startup, looks to China to challenge Bristol Myers heart drug - BioPharma Dive","headline":"Bravehart, a stealthy startup, looks to China to challenge Bristol Myers heart drug","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisgFBVV95cUxNdFNyUjFhUW9VNHlTSHVLSGdwQ1lRdm9zX1l4TklsZXhkV1JQUzRHM0JsdFlIb2dWdmV2dDBPQ2JVeHVwQmkxb0cyRzVsYmFhUkYyYy04WmpBVk1pdTlIMXNQSWtKLVFGSHR1U0doMzJiSXNaeDViT0w4Z1VJbXJEdEVXZ1ViTnRfSnhRUzdJNnRDdEZXeFluR1Q2dDctZnlfSERNd3VOazVmY21veUFHNkhn?oc=5","date":"2025-09-05","type":"pipeline","source":"Fierce Biotech","summary":"Led by ex-HI-Bio CEO, Braveheart pays $65M to challenge BMS for heart disease market - Fierce Biotech","headline":"Led by ex-HI-Bio CEO, Braveheart pays $65M to challenge BMS for heart disease market","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxQZEswWi1fMC05MVdWbnJCUWUteTFRRkxkb2lfbDkza1VtWjNGTm5GMzVYRjFTcVlVaEh3N2s1ei1EVlZLVWRwZmZlT1BIX3M0ZlpMQldlcGxRbzExQU00RHBTVDVsX3dzVzNNdVVuS1VHMUhsYVM0d3pzX3VNZ0xIOHlINTZRcVZDLVlBc2dzVHA1V2oySEJKZkphTUdJaGQyT2VfVklPclA?oc=5","date":"2024-05-16","type":"pipeline","source":"The Cardiology Advisor","summary":"Expanding Treatment Options: Novel Drug Therapies in the Pipeline for Heart Failure With Reduced Ejection Fraction - The Cardiology Advisor","headline":"Expanding Treatment Options: Novel Drug Therapies in the Pipeline for Heart Failure With Reduced Ejection Fraction","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxQNGs2b3BXUk8tTXVwX19zMjZYSTllU2F1S1h5cWRIT05WSTM3M2tXS3JQbV8tWTdmYUhrSTQxaDJWZHFaQWE5VHBNc3IxZE5yN3dDWU5xdWlQOGk1X2ZpRW1MOXlaYzE1RjZHNWRsWU9WQ0psUzlfQWxHdElIUjc5c1ZYVzZUaktXREpJTjF2NndJWHBia2YyME5ScXo?oc=5","date":"2024-05-14","type":"pipeline","source":"dicardiology.com","summary":"New Treatment in Pipeline for Patients with Hypertrophic Cardiomyopathy - dicardiology.com","headline":"New Treatment in Pipeline for Patients with Hypertrophic Cardiomyopathy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMickFVX3lxTE5hX2RaS1NsbEVYS3AyMkpaR1c1b0x0TDdjMGMxS2RjampURHNtQTBMUlk1cktCUlNqWDlsZ1ZPSUV3X1JpcmR2RUtTWnRWZ2thN29mZW93QnZqQWFGZjBFTi1jQzg3RGdBNWxpMGU1RC1DUQ?oc=5","date":"2024-01-16","type":"pipeline","source":"Labiotech.eu","summary":"Five biotech companies taking Florida by storm - Labiotech.eu","headline":"Five biotech companies taking Florida by storm","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}